For people with diabetes, the use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) is associated with a reduced risk for certain disorders and conditions.

Several years ago, a little-known drug named Ozempic — previously used only to treat diabetes — emerged as a promising new ...

The latest semaglutide (Ozempic; Novo Nordisk) approval is set to tackle a major need for patients with both type 2 diabetes ...

Boosting Bacteroides vulgatus in diabetic mice increased GLP-1 secretion, improving blood sugar control and reducing sugar ...

A study on GLP1RA medications found that behavioral side effects likely do not result from direct action on GLP1R.

Scientists may have discovered a way to naturally regulate blood sugar levels and sugar cravings that works similarly to ...

If your constipation lasts for more than three days, speak with your doctor about options to help. You might need to add a ...

Attribution (BY): Credit must be given to the creator. Lipidated analogues of glucagon-like peptide 1 (GLP-1) have gained enormous attention as long-acting peptide therapeutics for type 2 diabetes and ...

The Australian Open don’t own all of their broadcasting rights (fairly common), so they’re live-streaming a Wii Tennis-like version of ... on a two-minute delay. Cartoon Nick Kyrgios winces ...

The New Orleans post-punk crew returned last year with the songs “Routiner” and “Postcard,” and today they’re announcing their sophomore LP Like Cartoon Vampires. The electrifying lead ...

Researchers conducted a retrospective study to explore the potential of Glucagon-like peptide-1 (GLP-1) via GLP-1 receptor agonists (GLP-1RAs) as an alternative treatment for HO. They reviewed studies ...